1 recruiting, 1 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Recruiting 1, Unknown 1 |
Follow Relapse: new trials by email Literature Review of Relapse trials Research Report on Relapse
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MBRP + Vortioxetine VS MBRP on Preventing Relapse in Chronic MA Users Vortioxetine - Relapse, Cognitive Impairment | Phase 4 | Unknown | Sir Run Run Shaw Hospital | 220 | 2020-09-01 | 2019-11-29 |
| Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease Methimazole - Graves Disease, Relapse | Phase 4 | Recruiting | The First Affiliated Hospital with Nanjing Medical University | 240 | 2018-05-01 | 2023-12-11 |
Recurrence (2) · Cognitive Dysfunction (1) · Depression (1) · Graves Disease (1) · Substance Withdrawal Syndrome (1)
Disease Attributes (2) · Mental Disorders (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Autoimmune Diseases (1) · Behavior (1) · Behavioral Symptoms (1) · Chemically-Induced Disorders (1) · Cognition Disorders (1) · Endocrine System Diseases (1) · Exophthalmos (1) · Eye Diseases (1) · Goiter (1) · Hyperthyroidism (1) · Immune System Diseases (1)
Methimazole (1) · Vortioxetine (1)
Sir Run Run Shaw Hospital (1) · The First Affiliated Hospital with Nanjing Medical University (1)
China (1)
Tao Yang (1) · Xuqin Zheng (1) · Yanhui Liao, MD (1)